Cargando…

State of the art of services in Europe: where are the problems?

Detalles Bibliográficos
Autor principal:	Aymé, Ségolène
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958377/ http://dx.doi.org/10.1186/1750-1172-5-S1-O2

Ejemplares similares

State of the art of rare disease activities in Europe: a EUCERD perspective
por: Aymé, Ségolène
Publicado: (2012)

The European Union Committee of Experts on Rare Diseases (EUCERD): a new committee to help the European Commission advance in the field of rare disease policy
por: Moliner, Antoni Montserrat, et al.
Publicado: (2010)

Classification of rare diseases: a worldwide effort to contribute to the International Classification of Diseases
por: Rath, Ana, et al.
Publicado: (2010)

WHO International Classification of Diseases (ICD) Revision Process: incorporating rare diseases into the classification scheme: state of art
por: Aymé, Ségolène, et al.
Publicado: (2010)

How to code rare diseases with international terminologies?
por: Rath, Ana, et al.
Publicado: (2014)

Rare diseases research in Europe: an overview based on data from the Orphanet database
por: Martin, Natalia, et al.
Publicado: (2010)

Breast surgery: state of the art
por: Kissin, M
Publicado: (2006)

Imaging of the pancreas: state of the art
por: Morana, G, et al.
Publicado: (2015)

Genetic testing in Europe: transborder testing is a necessity
por: Jovanovic, Mariana, et al.
Publicado: (2010)

Where are macrophage-tropic viruses?
por: Schnell, G, et al.
Publicado: (2010)

Prediction models in multicenter studies: methodological aspects and current state of the art
por: Wynants, Laure, et al.
Publicado: (2015)

Scope of centres of expertise for rare diseases in European countries where they exist
por: Rodwell, Charlotte, et al.
Publicado: (2012)

O078: 6 years of national German hand hygiene campaign-where do we come from and where are we heading to?
por: Reichardt, C, et al.
Publicado: (2013)

Evolution of national and European policies in the field of rare diseases and their impact over the past five years
por: Rodwell, Charlotte, et al.
Publicado: (2014)

Mapping and modeling Dirofilaria infections in Europe
por: Rinaldi, L, et al.
Publicado: (2014)

Drilling down on the vitamin D debate: where are our priorities?
por: Ward, Leanne M
Publicado: (2015)

Intensive care medicine in europe: the state of the training art
por: Wong, A, et al.
Publicado: (2015)

Australia’s ‘silent pandemic’ of diabetes complications: where do feet stand in this pandemic?
por: Lazzarini, Peter A, et al.
Publicado: (2013)

Where is the family when we work with adult patients? An eating disorders perspective
por: Metres, Marie-Louise, et al.
Publicado: (2013)

Patient involvement and empowerment through the NPRD (Eastern Europe)
por: Dan, Dorica
Publicado: (2010)

Computational chemistry in pharmaceutical research – where do we stand after 25 years?
por: Köppen, Herbert
Publicado: (2012)

The added value of centres of expertise for rare disease patients in Europe
por: Kole, Anna A, et al.
Publicado: (2010)

Ten years of MRSA surveillance in Switzerland: similarities and differences with Europe
por: Olearo, F, et al.
Publicado: (2015)

Barriers to knowledge translation: from controlled scenario to clinical scenario in addictions treatment
por: Martínez Martínez, Kalina Isela, et al.
Publicado: (2015)

Reality check: where women look when viewing fashion magazine advertisements with disclaimer labels
por: Bury, Belinda, et al.
Publicado: (2013)

Epidemiology and models of care for mentally disordered prisoners in Europe – the EUPRIS study
por: Salize, Hans Joachim, et al.
Publicado: (2007)

Development of cannabinoid receptor (CB 2 R) ligands for application in PET studies - where to attach the radiolabel?
por: Günther, Robert, et al.
Publicado: (2014)

The present situation of Rare Diseases in Central/Eastern Europe? The role of patient organisations
por: Pogany, Gabor
Publicado: (2010)

Why we should have more collaboration on HTA in Europe: the example of sofosbuvir
por: Schelleman, Hedi, et al.
Publicado: (2015)

Improvement of child art program for tsunami evacuation support
por: Tamaho, Moriwaki, et al.
Publicado: (2019)

Promotion of health care workers immunization in Europe – the main objective of the HProImmune project
por: Pițigoi, Daniela, et al.
Publicado: (2013)

New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community
por: Hivert, Virginie, et al.
Publicado: (2010)

Quantification of aortic valve regurgitation by phase-contrast magnetic resonance in patients with bicuspid aortic valve: where to measure the flow?
por: Muzzarelli, Stefano, et al.
Publicado: (2013)

Socioeconomic determinants of medicines use in Central Eastern Europe: the role of pharmaceutical policy in reducing inequalities
por: Vogler, Sabine, et al.
Publicado: (2015)

Whom should we divert and to where? Looking at arrests in a 10-year cohort study of persons with severe mental illness
por: Fisher, William
Publicado: (2007)

The European Union Committee of Experts on Rare Diseases: three productive years at the service of the rare disease community
por: Aymé, Ségolène, et al.
Publicado: (2014)

Training load and health problems in freshman rowers
por: van Beijsterveldt, Anne-Marie, et al.
Publicado: (2015)

SHARE – workpackage 5: development of best practices of diagnosis and treatment for paediatric rheumatic diseases throughout Europe
por: Vastert, Sebastiaan, et al.
Publicado: (2014)

Comparison of the cost effectiveness of pre-service training and in-service training in Ethiopia
por: Berhe, Habtamu, et al.
Publicado: (2014)

Hypoventilation and sleep apnoea in spina bifida - an unrecognised problem?
por: Hillan, Josephine, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_b61oi4vc2dharo6h0p16d1523v